Allen Lising of Xcenda sits down with The Center for Biosimilars

AMJC | The Center for Biosimilars

Speaking with AJMC, Xcenda's Allen Lising, managing director of FormularyDecisions, explains how stakeholders are using pre-approval information to make business decisions. He also discussed the Biosimilars Hub within FormularyDecisions, as well as the launch of ICER Analytics, a cloud-based platform that's revolutionizing how payers, pharma, and patient groups develop formularies, negotiate drug prices, and explore new ways to apply evidence equitably.
screenshot of Allen Lising video call

AMJC | The Center for Biosimilars® 

Xcenda's Allen Lising discusses the growing emphasis on biosimilar pipeline information